Related Experiment Video
Updated: Mar 27, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
Food Insecurity and Poverty Are Associated with Increased Risk for MASLD Among US Adults
Kyle S Liu1, Keith E Liu2, Itunu O Sokale3,4
1Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.
Background And Aims:
The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) is increasing and disproportionately affects minority populations in the U.S. Racial and ethnic minority groups experience higher rates of food insecurity and poverty. We examined the associations between food insecurity, poverty, and risks of MASLD and moderate fibrosis overall and across racial and ethnic groups.
Methods:
We used the 2017-2020 National Health and Nutrition Examination Survey data. The inclusion criteria for the current study were being aged ≥ 20 years, being interviewed at home and in a mobile examination center, having undergone Fibroscan, and having available data for food security, poverty ratio, and ethnicity questionnaire components. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using weighted multivariate logistic regression models.
Results:
Of the 5741 respondents, 1966 (33.8 weighted %) had MASLD, including 525 (27.0%) with moderate fibrosis. Very low (Adjusted OR [AOR] 1.61; 95% CI 1.27-2.03) food security and poverty index < 1.30 (AOR 1.29; 95% CI 1.03-1.62) were statistically significantly associated with increased risk for MASLD. When stratified by race/ethnicity, the association between very low food security and MASLD only remained statistically significant in non-Hispanic white (NHWs; AOR 1.96; 95% CI 1.34-2.87) individuals. Poverty was not statistically significantly associated with MASLD in analyses stratified by race/ethnicity.
Conclusions:
Food insecurity and poverty were associated with MASLD risk. When stratified by race/ethnicity, food insecurity remained associated with MASLD only in the NHW population. Further studies and tailored interventions are needed to address food insecurity and poverty and the impact on liver disease.
More Related Videos
Related Concept Videos
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Obesity
Cholesterol: Significance and Regulation
Considering cholesterol and...

